HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meropenem versus tobramycin with clindamycin in the antibiotic management of patients with advanced appendicitis.

AbstractBACKGROUND:
Meropenem (MP), a new carbapenem antibiotic, has excellent antimicrobial activity against the enteric flora commonly encountered in acute appendicitis. Although similar to imipenem, it may have clinical advantages.
STUDY DESIGN:
We compared patients with advanced appendicitis (gangrenous or perforated) treated with 1,000 mg MP every eight hours with those given the combination of tobramycin 5 mg/kg/day at eight hour intervals and clindamycin 900 mg every eight hours. Both treatments were given intravenously. Patients were randomized to either group of the double-blind study.
RESULTS:
Of 129 evaluable cases, 63 received MP and 66 received both tobramycin and clindamycin (T/C). The two groups were similar in age, sex, and severity of disease. The mean number of days of postoperative fever (MP = 3.1 +/- 1.7 SD compared to T/C = 4.4 +/- 2.2 SD, p < or = 0.01), days of antibiotic therapy (MP = 6.1 +/- 1.6 SD compared to T/C = 7.3 +/- 2.2 SD, p = 0.01), and therefore hospital stay (MP = 8.0 +/- 3.5 SD compared to T/C = 9.4 +/- 2.6 SD, p < 0.01) were significantly better for patients treated with MP. No difference was found between the numbers of failures in each group (MP = 5 compared to T/C = 6).
CONCLUSIONS:
This study demonstrates a small but significant reduction (approximately one day) in post-operative fever, duration of antibiotic treatment, and hospital stay for patients treated with MP compared to those treated with T/C.
AuthorsT V Berne, A E Yellin, M D Appleman, P N Heseltine, M A Gill
JournalJournal of the American College of Surgeons (J Am Coll Surg) Vol. 182 Issue 5 Pg. 403-7 (May 1996) ISSN: 1072-7515 [Print] United States
PMID8620275 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Thienamycins
  • Clindamycin
  • Meropenem
  • Tobramycin
Topics
  • Adult
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Appendicitis (drug therapy)
  • Clindamycin (administration & dosage, therapeutic use)
  • Double-Blind Method
  • Drug Administration Schedule
  • Drug Therapy, Combination (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Intestinal Perforation (drug therapy)
  • Length of Stay
  • Male
  • Meropenem
  • Rupture, Spontaneous
  • Thienamycins (therapeutic use)
  • Time Factors
  • Tobramycin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: